Navigation Links
David H. Murdock Research Institute Assumes Control of the Immune Tolerance Institute and Establishes a State of the Art Human Immune Monitoring Laboratory for Biomarker Discovery and Development
Date:6/9/2011

KANNAPOLIS, N.C., June 9, 2011 /PRNewswire/ -- The David H. Murdock Research Institute (DHMRI) today announced the acquisition of the Immune Tolerance Institute, Inc. (ITI) as a next step in the continued growth of the Institute, located on the North Carolina Research Campus in Kannapolis, NC. Driven by a mission to accelerate the discovery and development of breakthrough treatments for the range of immune-related diseases, the DHMRI provides integrated, state-of-the-art genomic, cellular, proteomic and bioinformatics technology platforms as a major resource for a range of academic and industry partners undertaking both preclinical and clinical research. By acquiring ITI, DHMRI is enhancing its already comprehensive and unique set of collocated capabilities to accelerate the discovery of novel immunomodulatory therapies and of the corresponding biomarkers necessary for their effective translation into medical practice.

Biomarkers can help to better predict the course of disease progression, the likelihood of an individual's response to diet or therapeutic intervention, as well as serving as surrogate endpoints of mechanism, efficacy, and safety.  Indeed, biomarkers were cited in the FDA's Critical Path Opportunities Report as one of the most critical areas for improving the quality, success rate, development time and cost effectiveness of medicine development. Equivalent bioanalytical approaches are becoming increasingly applied in the agricultural and nutritional areas to provide an objective scientific assessment of both the dietary composition of the foods and their functional effects on the immune and other physiological systems.  

"Advancing immune science will lead to new approaches to investigate the biological mechanisms of disease and functional properties of foods to better determine and predict the efficacy and safety of emerging products.   Such efforts have the potential to benefit human health and disease management and reverse the recent trends that have led to higher costs of health care and slowed the pace of new treatment development," said Mike Luther of the DHMRI.  "The acquisition of ITI will allow us to extend the DHMRI's capabilities even further into the pre-clinical and clinical settings, and thus provide increasingly integrated solutions from discovery into development, ultimately improving the health of patients and consumers alike."

About the DHMRI

 Established as a nonprofit organization through a private grant by David H. Murdock, the DHMRI is a catalyst in the development of the North Carolina Research Campus (NCRC) as a world class research facility. Research is performed with academic and industry partners to understand the mechanistic basis of diseases, to support the development of medicinal or nutritional intervention therapies and to identify potential biomarkers to accelerate the progression of those discoveries into medical practice. The DHMRI's state-of-the-art technologies include diverse, complementary and integrated platforms under one roof to provide unprecedented bioanalytical capabilities, including next-generation genetics and genomics, advanced characterization of proteins and metabolites ,.  In addition, the assessment of cellular structure and function using cutting-edge confocal imaging complimented by interventional studies in various in vivo settings. With the integration of the Immune Tolerance Institute, the Institute is now supporting numerous clinical trials of immunomodulatory therapies and approaches with advanced flow cytometry, immunoassay and gene expression methods across a range of immune-related studies.. The broad spectrum of capabilities and expertise resident at the DHMRI and the wider NCRC facilitates an unprecedented level of scientific collaboration and public-private partnership for research at the intersection of human health, nutrition, and agriculture. (www.dhmri.org/about.html)

About ITI

The Immune Tolerance Institute (ITI) is a 501 (c)(3) non-profit corporation founded to fill critical unmet needs for translating fundamental scientific discoveries into new therapies for the broad range of diseases related to the human immune system, including autoimmune diseases, allergy, asthma, cancer, and cardiovascular and infectious diseases. Since 2007 ITI's technologies have been deployed for a range of both academic and industry partners to perform comprehensive cellular and molecular immunological analyses during clinical trials of emerging immune therapeutics, in order to identify novel biomarkers that can predict disease activity, drug safety and efficacy, and serve as companion diagnostics that advance personalized medicine by matching the right patients with the right therapies at the right time.


'/>"/>
SOURCE ITI
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Omeros Appoints David A. Mann to its Board of Directors
2. [video] David Brown, President and CEO of LifeVantage Corporation, Discusses Record Page Views on WallSt.nets 3-Minute Press Show
3. Encorium Appoints David Ginsberg President and Chief Executive Officer, Announces Changes to the Board of Directors
4. Trusted LASIK Surgeons Welcomes Leading LASIK Eye Surgery Expert, Inventor David Huang, M.D., Los Angeles, to Its Unique Lasik Directory Service
5. David Hsia, Ph.D. Joins Kinex Pharmaceuticals Board of Directors
6. Lumiphore Partners with Biophor Diagnostics, Inc. to Develop Tests for Drugs of Abuse; Appoints Ibis Biosciences Founder David J. Ecker to Board
7. Pacira Pharmaceuticals, Inc. Adds Experienced Physician Dr. David St. Peter to Leadership Team
8. David H. Murdock Research Institute Taps Waters for Laboratory Technology
9. PercSys Names David Auth and Howard Palefsky to Its Board of Directors
10. Prominent Urologist Dr. David B. Samadi Presents Breakthrough Robotic Surgery Techniques on OR Live Webcast
11. BrainCells Inc. Appoints David E. Thompson to Its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2017)... ... September 21, 2017 , ... Lajollacooks4u welcomed the San Diego chapter of Les ... society of professional women with high achievement in the fields of food, fine beverage ... , Twelve members began with an olive oil tasting to whet their palettes and ...
(Date:9/20/2017)... ... September 20, 2017 , ... The award-winning producers ... (Koch) to feature new innovations aimed at helping farmers solve the problem of ... Farmer airs Tuesdays at 8:30aET on RFD-TV. Check your local listings for more ...
(Date:9/20/2017)... ... ... Diversity focused business accelerator, The Refinery , announced today they are ... top technology-driven, women-led startups in Boston, MA, New Haven/Hamden, CT, and Newark, NJ. ... on that week – in Boston, it will be part of the City of ...
(Date:9/20/2017)... ... 20, 2017 , ... Proscia Inc. , a data ... of whole slide imaging solutions, are hosting a pre-conference workshop at the ... a Best-in-Class Strategy for Digital Pathology,” will feature Proscia CEO, David West Jr., ...
Breaking Biology Technology:
(Date:3/29/2017)... , March 29, 2017  higi, the health ... in North America , today announced ... and the acquisition of EveryMove. The new investment and ... set of tools to transform population health activities through ... lifestyle data. higi collects and secures data ...
(Date:3/24/2017)... The Controller General of Immigration from Maldives Mr. Mohamed Anwar ... prestigious international IAIR Award for the most innovative high security ePassport and ... ... Maldives Immigration Controller General, Mr. Mohamed ... the right) have received the IAIR award for the "Most innovative high ...
(Date:3/23/2017)... -- Research and Markets has announced the addition of ... Industry Forecast to 2025" report to their offering. ... The Global Vehicle Anti-Theft ... 8.8% over the next decade to reach approximately $14.21 billion by ... and forecasts for all the given segments on global as well ...
Breaking Biology News(10 mins):